On Thursday, September 19th, at 4:00pm at the UW CoMotion - Fluke Hall, regulatory partner Eva Yin will be participating in Nucleate Seattle’s most recent installment in the Genesis Lecture Series, an engaging panel on Clinical Development Pathways for biotech companies. Come gain insight into how biotech companies prepare for clinical validation and learn more about the FDA/health regulations that are required before bringing innovations to market.

​Come hear from Eva, Shannon Eubanks (Proprio Visio), Ajoke Sobanjo-ter Meulen, M.D. (AstraZeneca), and Arna Stoll (Wavely Diagnostics) about how to navigate these regulatory processes and how to incorporate these during the development of your product.

​This event will provide practical advice on transitioning from academia to bio-entrepreneurship, and provide critical insight into how biotech companies prepare for clinical validation. Don’t miss this opportunity to learn from and network with industry leaders.